title: Bortezomib (Velcade) treatment of AL amyloidosis: Indiana University experience.
authors.affiliation: Section of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
authors.forename: R
authors.initials: R
authors.lastname: Abonour
authors.forename: G
authors.initials: G
authors.lastname: Kramer
authors.forename: A
authors.initials: A
authors.lastname: Suvannasankha
authors.forename: M D
authors.initials: MD
authors.lastname: Benson
mesh_terms: D000328:Adult; D000368:Aged; D000686:Amyloidosis / Q000188:drug therapy*; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D005260:Female; D006801:Humans; D007147:Immunoglobulin Light Chains; D007196:Indiana; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000627:therapeutic use*
chemical_list: D001897:Boronic Acids; D007147:Immunoglobulin Light Chains; D011719:Pyrazines; D000069286:Bortezomib